交易 | 地址 | 数量 |
---|---|---|
fb99bc...c872c5
|
the-void |
-
6.27255899 LTC
·
679.63 USD
|
fb99bc...c872c5
|
LcNS6c...osnkN3
|
+
6.27255899 LTC
·
679.63 USD
|
fb99bc...c872c5
|
script-1e1c1ec29a9e2d6e10790ed5393a2704 |
+
0 LTC
·
0.00 USD
|
c08ba5...f9d6e7
|
LPtA4V...iiDbXX
|
-
53.03665098 LTC
·
5,746.52 USD
|
c08ba5...f9d6e7
|
MUCh8y...j6ufsW
|
+
1 LTC
·
108.35 USD
|
c08ba5...f9d6e7
|
LPtA4V...iiDbXX
|
+
52.03474098 LTC
·
5,637.96 USD
|
c08ba5...f9d6e7
|
the-void |
+
0.00191 LTC
·
0.20 USD
|
6060f5...0e1e75
|
ltc1q9...8s3apj
|
-
0.01176724 LTC
·
1.27 USD
|
6060f5...0e1e75
|
ltc1qv...st9he6
|
+
0.01100208 LTC
·
1.19 USD
|
6060f5...0e1e75
|
the-void |
+
0.00076516 LTC
·
0.08 USD
|
MEI Pharma completes $100 million private placement to purchase Litecoin as reserve asset, first publicly traded company to do so.
LD Capital创始人JackYi分析认为,加密货币牛市具有轮动上涨规律,山寨币可能在最后补涨。
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.